首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1609698

2025-2033 年日本重组蛋白市场报告（按产品、应用、最终用户和地区）

Japan Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024 年，日本重组蛋白IMARC Group规模达到 2.657 亿美元。单株抗体、疫苗和治疗性蛋白质等生物製药的快速发展正在推动市场发展，这些药物越来越多地用于治疗各种疾病，包括癌症、自体免疫疾病和传染病。

重组蛋白是透过结合不同来源的遗传物质（通常是来自能够产生特定蛋白质的生物体的 DNA）和宿主生物体用于蛋白质生产的细胞机制相结合而产生的人工工程蛋白质。该过程是生物技术和製药行业不可或缺的一部分，可以大规模生产用于各种应用的特定蛋白质。为了创建重组蛋白，科学家将所需的基因序列插入宿主生物体，如细菌、酵母菌或哺乳动物细胞。一旦宿主生物体吸收了外源DNA，它就开始根据插入的遗传指令产生目标蛋白质。重组蛋白具有多种应用，包括生产治疗药物（例如胰岛素或疫苗）、研究工具（例如酵素和抗体）以及用于各种製程（例如生物燃料生产或食品加工）的工业酵素。它们的生产可以实现精确控制、可扩展性和纯度，这使得它们对于推进医疗、科学和工业领域至关重要。

日本重组蛋白市场趋势：

有几个因素推动了日本重组蛋白市场的发展。首先，癌症、糖尿病和自体免疫疾病等慢性疾病的发生率不断上升，对透过重组 DNA 技术生产的治疗性蛋白质的需求不断增长。因此，製药公司正大力投资新型生物製药的开发，推动市场向前发展。此外，基因工程和生物技术的进步改进了重组蛋白的生产过程。增强的表达系统，例如哺乳动物和酵母细胞系，能够生产产量更高、品质更好的复杂蛋白质，从而推动市场扩张。除此之外，蛋白质体学和基因组学领域研发活动的激增增加了对重组蛋白作为研究工具的需求。这些蛋白质对于研究基因功能、蛋白质-蛋白质相互作用和药物发现以及促进市场成长至关重要。此外，个人化医疗的采用以及双特异性抗体和融合蛋白的开发为治疗蛋白产业开闢了新的机会，预计将在预测期内推动日本重组蛋白市场的发展。

日本重组蛋白市场细分：

产品见解：

抗体
荷尔蒙
生长因子
细胞因子
其他的

应用见解：

药物发现与开发
学术研究
生物技术研究
生物製药生产
其他的

最终使用者见解：

製药和生物製药公司
生技公司
学术及研究机构
合约研究组织
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本重组蛋白市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本重组蛋白市场有何影响？
日本重组蛋白市场的产品结构如何？
日本重组蛋白市场在应用上的细分如何？
日本重组蛋白市场的最终用户细分如何？
日本重组蛋白市场价值链的各个阶段是什么？
日本重组蛋白的关键驱动因素和挑战是什么？
日本重组蛋白市场的结构如何？
日本重组蛋白市场的竞争程度如何？

本报告回答的关键问题：

日本重组蛋白市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本重组蛋白市场有何影响？
日本重组蛋白市场的产品结构如何？
日本重组蛋白市场在应用上的细分如何？
日本重组蛋白市场在最终用户方面的细分情况如何？
日本重组蛋白市场价值链的各个阶段是什么？
日本重组蛋白的关键驱动因素和挑战是什么？
日本重组蛋白市场的结构如何？
日本重组蛋白市场的竞争程度如何？

抗体
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
荷尔蒙
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
生长因子
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
细胞因子
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 7 章：日本重组蛋白市场 - 细分：依应用分类

药物发现与开发
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
学术研究
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
生物技术研究
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
生物製药生产
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 8 章：日本重组蛋白市场 - 细分：依最终用户划分

製药和生物製药公司
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
生技公司
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
学术及研究机构
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
合约研究组织
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 9 章：日本重组蛋白市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 10 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本重组蛋白市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 12 章：附录

简介目录

Product Code: SR112024A19281

Japan recombinant protein market size reached USD 265.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 576.6 Million by 2033, exhibiting a growth rate (CAGR) of 9% during 2025-2033. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.

Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.

Japan Recombinant Protein Market Trends:

Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.

Japan Recombinant Protein Market Segmentation:

Product Insights:

Antibodies
Hormones
Growth Factors
Cytokines
Others

Application Insights:

Drug Discovery and Development
Academic Research
Biotechnology Research
Biopharmaceutical Production
Others

End User Insights:

Pharmaceutical and Biopharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organization
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan recombinant protein market?
What is the breakup of the Japan recombinant protein market on the basis of product?
What is the breakup of the Japan recombinant protein market on the basis of application?
What is the breakup of the Japan recombinant protein market on the basis of end user?
What are the various stages in the value chain of the Japan recombinant protein market?
What are the key driving factors and challenges in the Japan recombinant protein?
What is the structure of the Japan recombinant protein market and who are the key players?
What is the degree of competition in the Japan recombinant protein market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Recombinant Protein Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Recombinant Protein Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Recombinant Protein Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Hormones
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Growth Factors
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Cytokines
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2019-2024)
- 6.5.2 Market Forecast (2025-2033)

7 Japan Recombinant Protein Market - Breakup by Application

7.1 Drug Discovery and Development
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Academic Research
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Biotechnology Research
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Biopharmaceutical Production
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Recombinant Protein Market - Breakup by End User

8.1 Pharmaceutical and Biopharmaceutical Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Biotechnology Companies
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Academic and Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Contract Research Organization
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Recombinant Protein Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Recombinant Protein Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis